Haemonetics Corporation (HAE) Insider Trading
- $2,100,000.00
- $98,302,276.98
- July 26, 2024
- Dan Goldstein
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 1, 2014 | CEO | 4,600 | $32.71 | Sell | $150,466.00 | |
March 6, 2014 | Director | 12,000 | $36.17 | Sell | $434,040.00 | |
March 3, 2014 | CEO | 4,600 | $36.36 | Sell | $167,256.00 | |
Feb. 18, 2014 | VP | 3,690 | $39.00 | Sell | $143,910.00 | |
Feb. 7, 2014 | Insider | 1,880 | $38.66 | Sell | $72,680.80 | |
Feb. 3, 2014 | CEO | 7,600 | $37.63 | Sell | $285,988.00 | |
Jan. 27, 2014 | VP | 3,206 | $38.37 | Sell | $123,014.22 | |
Jan. 10, 2014 | VP | 4,000 | $41.80 | Sell | $167,200.00 | |
Jan. 2, 2014 | CEO | 7,600 | $41.58 | Sell | $316,008.00 | |
Dec. 16, 2013 | VP | 4,000 | $43.50 | Sell | $174,000.00 | |
Dec. 9, 2013 | VP | 3,138 | $43.07 | Sell | $135,153.66 | |
Dec. 2, 2013 | CEO | 7,600 | $42.31 | Sell | $321,556.00 | |
Nov. 12, 2013 | Insider | 61,400 | $39.70 | Sell | $2,437,580.00 | |
Nov. 1, 2013 | CEO | 7,600 | $39.96 | Sell | $303,696.00 | |
Oct. 14, 2013 | Insider | 1,400 | $40.41 | Sell | $56,574.00 | |
Sept. 13, 2013 | Insider | 1,400 | $40.36 | Sell | $56,504.00 | |
Sept. 3, 2013 | CEO | 13,000 | $39.87 | Sell | $518,310.00 | |
Aug. 1, 2013 | CEO | 13,000 | $42.24 | Sell | $549,120.00 | |
July 12, 2013 | Insider | 1,400 | $44.10 | Sell | $61,740.00 | |
July 1, 2013 | CEO | 13,000 | $41.87 | Sell | $544,310.00 | |
June 18, 2013 | CFO | 68,628 | $42.50 | Sell | $2,916,690.00 | |
June 14, 2013 | Insider | 1,400 | $42.17 | Sell | $59,038.00 | |
June 3, 2013 | CEO | 13,000 | $41.15 | Sell | $534,950.00 | |
May 21, 2013 | CFO | 42,882 | $42.00 | Sell | $1,801,044.00 | |
May 14, 2013 | Insider | 1,400 | $39.66 | Sell | $55,524.00 | |
May 1, 2013 | CEO | 13,000 | $38.66 | Sell | $502,580.00 | |
Dec. 3, 2012 | CEO | 13,000 | $40.75 | Sell | $529,750.00 | |
Nov. 12, 2012 | Director | 16,000 | $80.40 | Sell | $1,286,400.00 | |
Sept. 4, 2012 | CFO | 61,783 | $74.34 | Sell | $4,592,948.22 | |
Sept. 4, 2012 | CEO | 6,500 | $73.68 | Sell | $478,920.00 |
Insiders are both buying and selling Haemonetics Corporation stock.
The insider traders at Haemonetics Corporation are: Dan Goldstein, Brian Concannon, Christopher Simon, William P. Mr. Burke, Jacqueline Scanlan, Michelle L. Basil, Josep Llorens, Christopher J Lindop, Stewart W Strong, Anila Lingamneni, Michelle L Basil, Laurie A Miller, Susan Hanlon, Pedro P Granadillo, Ronald Merriman, Ronald G Gelbman, Michael Kelly, Michael P Kelly, Ronald G. Gelbman, Susan Bartlett Foote, Susan M Hanlon, Richard J. Meelia, Mark W Kroll, Mark W. Kroll, Jonathan White, Neil Mr. Ryding, Pedro Granadillo, Pedro P. Granadillo, Peter M Allen, Said Bolorforosh, Christopher J. Lindop, Sandra Jesse, Ronald Gelbman, Peter Allen, Willaim P Burke, and Byron Selman
The most active insider trader at Haemonetics Corporation is Dan Goldstein with 28 trades.
Christopher Simon has sold the most Haemonetics Corporation stock with a total value of $22,424,866.91.
Christopher Simon has bought the most Haemonetics Corporation stock with a total value of $4,200,000.00.
The most recent insider trade for Haemonetics Corporation was on July 26, 2024.
The single biggest insider buy for Haemonetics Corporation was from Christopher Simon with a total value of $2,100,000.00 on Aug. 4, 2016.
The single biggest insider sell for Haemonetics Corporation was from Christopher Simon with a total value of $6,990,926.67 on Aug. 19, 2019.